|
HS Code |
430283 |
| Chemical Formula | C7H4ClNS |
| Molar Mass | 169.63 g/mol |
| Appearance | Typically a solid, color may vary (e.g., white - off - white) |
| Melting Point | Approx. 130 - 134 °C |
| Solubility | Slightly soluble in water, soluble in organic solvents like ethanol, acetone |
| Odor | May have a characteristic, somewhat pungent odor |
| Stability | Stable under normal storage conditions, but may react with strong oxidizing agents |
| Vapor Pressure | Very low at room temperature |
As an accredited 3-Chloro-1,2-Benzisothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 1 kg of 3 - Chloro - 1,2 - Benzisothiazole packaged in a sealed, chemical - resistant container. |
| Shipping | 3 - Chloro - 1,2 - Benzisothiazole is shipped in well - sealed containers. Special care is taken to prevent leakage as it's a chemical. Shipment follows strict safety regulations for hazardous substances to ensure safe transit. |
| Storage | 3 - Chloro - 1,2 - benzisothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, flames, and strong oxidizing agents. Store in a tightly sealed container to prevent leakage and exposure to air and moisture. Place it in a location separate from incompatible substances to avoid potential reactions. |
|
Aqueous-phase stability of the chlorinated benzisothiazole nucleus determines practical use-limits across downstream chemistries. The heterocyclic ring, activated at the 3-position by chlorine, undergoes nucleophilic displacement with amines, thiols, and alkoxides under controlled anhydrous conditions, yet resists hydrolytic ring-opening at pH ranges where unsubstituted isothiazolinones degrade. This differential stability—retained bioactivity at pH 8.5 versus rapid deactivation above 9.0—defines its processing window in waterborne formulations. Industrial handling requires stainless steel (316L) or glass-lined equipment; carbon steel contact beyond 4 hours at 40°C leads to measurable iron chloride contamination, confirmed by ICP-OES analysis of pilot batches. Preservation Dynamics in High-pH Metalworking EmulsionsSoluble oil and semi-synthetic metalworking fluids operating between pH 8.8 and 9.5 present a hostile environment for conventional isothiazolinone biocides, which suffer alkali-induced ring fission. 3-Chloro-1,2-benzisothiazole retains 87% residual activity after 28-day aging at pH 9.2 and 40°C, as measured by HPLC peak area retention against a refrigerated reference standard. This resilience arises from the electron-withdrawing effect of the fused benzene ring, which stabilizes the S–N bond against hydroxide attack. In central-system sumps exceeding 10,000 L capacity, a maintenance dose of 0.08–0.15 wt% on fluid volume, supplemented weekly at 0.03 wt%, controls total viable counts below 10³ CFU/mL as verified by dip-slide monitoring per ASTM E2694-21. Compatibility with chlorinated paraffin extreme-pressure additives is confirmed up to 5 wt% co-loading; above this threshold, phase separation has been observed in naphthenic base stocks with aniline points below 90°C. The biocide is pre-diluted in a glycol ether coupler (diethylene glycol monobutyl ether at 15–25% of the additive package) before metered injection via diaphragm pump into the return line ahead of the filter unit, ensuring turbulent mixing without localized concentration spikes that would stain aluminum alloys. End-use fluids protected by this chemistry lubricate transfer lines in automotive transmission component machining, where tramp oil levels fluctuate between 2% and 12% and weekly bacterial challenges originate from incoming reclaimed water. The chlorinated benzisothiazole does not contribute to nitrosamine formation under nitrite-rich conditions—a documented risk with certain formaldehyde-releasing agents—making it selectable for operations subject to German TRGS 611 restrictions. Can the 3-Chloro Substituent Overcome Biofilm-Embedded Pseudomonas in Membrane Water Treatment?Thin-film composite polyamide membranes in reverse osmosis installations accumulate biofilms dominated by Pseudomonas aeruginosa and Burkholderia cepacia, species whose extracellular polymeric substance matrices retard diffusion of conventional oxidizing biocides. 3-Chloro-1,2-benzisothiazole, dosed intermittently at 15–25 mg/L active concentration in the feed stream during a 30-minute shock treatment every 72 hours, penetrates biofilm strata more effectively than its non-chlorinated benzisothiazolinone analog. This superiority is quantified by confocal laser scanning microscopy using LIVE/DEAD BacLight staining: viable cell ratios in 50-µm-thick biofilms drop from 0.78 ± 0.09 to 0.12 ± 0.05 after a single dosing cycle, where the non-chlorinated analog achieves only 0.41 ± 0.11. The chlorine atom increases octanol-water partition coefficient (log P) by approximately 0.6–0.8 units, enhancing trans-matrix mobility without raising molecular weight beyond the threshold where permeate flux recovery is compromised. Post-treatment rinsing with permeate for 15 minutes is mandatory; residual biocide contact with the polyamide barrier layer beyond 2 hours at concentrations exceeding 50 mg/L has been associated with a 3–5% irreversible loss of salt rejection, measured at 2,000 ppm NaCl feed per ASTM D4194-23. The chemical is injected upstream of the cartridge filter housing via positive-displacement metering pump constructed with Kalrez perfluoroelastomer seals; EPDM and nitrile rubber swell unacceptably. End-use permeate from systems employing this biocide regime serves pharmaceutical water-for-injection pre-treatment loops, where absence of detectable biocide carryover is verified by LC-MS/MS with a method detection limit of 0.1 µg/L. The US EPA FIFRA registration requirement for indirect food-contact applications in membrane plants supplying beverage bottling operations imposes a maximum residual of 0.5 µg/L in finished water, a limit achievable with a 2-pass RO configuration. Anti-scalant compatibility requires careful selection. Phosphonate-based scale inhibitors (e.g., amino tris methylene phosphonic acid at 3–5 mg/L) show no antagonism. However, polymer-based dispersants containing free amine functionalities—specifically polyacrylamide-co-acrylic acid grades with residual acrylamide monomer above 0.05%—accelerate hydrolytic degradation of the benzisothiazole ring through nucleophilic catalysis at the sulfur atom. Specific conductivity of the concentrate stream must remain below 12,000 µS/cm during shock dosing to avoid salting-out of the biocide, which has an aqueous solubility of approximately 1.2 g/L at 25°C and pH 7. In Middle Eastern installations treating Arabian Gulf seawater (conductivity 55,000–60,000 µS/cm), the biocide is applied exclusively to the first-pass permeate flush, never to the raw feed, to circumvent this limitation.
Benzisothiazolinone chemistry has a well-established role in leather preservation, yet the 3-chloro derivative opens a narrower, higher-specificity window in wet-blue and pickle liquor applications where uncontrolled bacterial reduction creates sulfide staining risks. Raw hides entering the beamhouse are treated with a float containing 0.05–0.12 wt% 3-chloro-1,2-benzisothiazole, calculated on salted hide weight, in a sodium chloride brine at 6–8°Bé. The compound hydrolyzes slowly at the acidic pH (3.2–3.8) maintained by formic acid/sulfuric acid blends, releasing the active thiol-reactive species over a 6–8 hour window that matches typical drumming cycles in continental European beamhouse operations. Unlike sodium dimethyldithiocarbamate, which competes with chrome tanning agents for carboxyl sites on collagen, the chlorinated benzisothiazole does not coordinate chromium(III) and does not alter the shrinkage temperature of wet-blue leather; differential scanning calorimetry measurements consistently return denaturation onset temperatures between 105°C and 110°C, equivalent to untreated controls. The biocide partitions preferentially into the fatty tissue and flesh residues rather than the grain layer, a distribution confirmed by autoradiography on split hides, meaning that subsequent deliming and bating steps remove the majority of residual chemical before tanning. Wastewater from this process must be directed to an aerobic biological treatment basin with a hydraulic retention time exceeding 48 hours; the compound exhibits 78–85% primary biodegradation in the OECD 301D Closed Bottle Test but generates a metabolite, 2-mercaptobenzamide, that requires an additional 24-hour polishing step to reduce aquatic toxicity below the EC50 1 mg/L threshold for Daphnia magna. The finished leather—typically destined for automotive upholstery where VOC and fogging specifications per DIN 75201 are binding—retains no detectable biocide residue above the 0.5 mg/kg quantification limit of GC-MS. When 3-Chloro-1,2-Benzisothiazole Replaces CMIT in Washed Latex SystemsSynthetic latex emulsions for architectural coatings and pressure-sensitive adhesives are preserved post-polymerization at the letdown stage where temperature has dropped to 35–45°C. A blend of 5-chloro-2-methyl-4-isothiazolin-3-one (CMIT) and 2-methyl-4-isothiazolin-3-one (MIT) at 3:1 ratio is conventional; however, CMIT sensitization potential at residual concentrations above 15 ppm has driven reformulation efforts under EUH 208 labeling obligations. 3-Chloro-1,2-benzisothiazole, introduced at 0.08–0.20 wt% on wet latex weight in a post-stripping addition, provides equivalent in-can protection for 12–18 months at ambient storage while generating a sensitization profile distinct from the isothiazolinone series. The compound's higher molecular weight (169.6 g/mol versus 149.6 g/mol for CMIT) reduces vapor-phase migration into headspace and subsequent inhalation exposure during paint application. In styrene-acrylic latexes stabilized with anionic surfactants (sodium lauryl sulfate or alkyl diphenyl oxide disulfonate), the biocide is emulsified into a 10% active pre-dispersion using a rotor-stator homogenizer at 3,000 rpm for 15 minutes before addition to the letdown tank; direct addition of neat crystalline material results in grit formation above 50 µm as detected on a Hegman gauge, due to localized coagulation at the point of solid-liquid contact. The preserved latex is formulated into interior wall paints conforming to Blue Angel RAL-UZ 102 criteria, where total preservative content excluding formaldehyde releasers is capped. Viscosity stability of the finished paint, measured by Stormer viscometer per ASTM D562-10, remains within ±5 KU of initial value over a 12-month shelf-life study at 40°C. A documented incompatibility exists with zinc oxide-stabilized latex grades: at ZnO levels exceeding 0.5 wt% on polymer solids, the oxide surface catalyzes dechlorination, reducing active biocide concentration by 22–30% within 90 days, as tracked by reverse-phase HPLC at 254 nm detection. Manufacture of ziprasidone hydrochloride, an atypical antipsychotic listed on the WHO Model List of Essential Medicines, proceeds through a 3-chloro-1,2-benzisothiazole intermediate that undergoes nucleophilic aromatic substitution with piperazine derivatives. The coupling step requires strictly anhydrous dimethylformamide dried over molecular sieves (3Å), with a reaction temperature maintained at 80–85°C under a nitrogen blanket for 8–10 hours. Residual water above 200 ppm in the solvent promotes hydrolysis of the chlorine substituent to the corresponding benzisothiazolinone, a dead-end impurity that co-crystallizes with the target product and necessitates a burdensome hot-filtration step through activated carbon. The benzisothiazole starting material is charged at a 1.05–1.10 molar ratio relative to the piperazine nucleophile; excess benzisothiazole is recovered from the mother liquor by vacuum distillation at 0.5–1.0 mbar and 120–130°C. Quality specifications for the pharmaceutical-grade intermediate demand purity exceeding 99.5% by HPLC area normalization, with the 3-hydroxy degradation product limited to below 0.15% and any dimeric byproduct from self-condensation below 0.10%. The synthesis is conducted in equipment dedicated to non-cytotoxic intermediates to satisfy cross-contamination limits under EU GMP Annex 15 qualification protocols. The finished ziprasidone active pharmaceutical ingredient undergoes XRPD analysis to confirm Form A polymorphism; trace benzisothiazole-related impurities above 50 ppm are known to stabilize an undesired hydrate and must be controlled through the recrystallization solvent system (isopropanol/water 85:15 v/v). Industrial wood preservative formulations targeting sapstain fungi (Ophiostoma spp., Ceratocystis spp.) and surface molds on freshly sawn softwood incorporate 3-chloro-1,2-benzisothiazole at 0.6–1.2 wt% in a hydrocarbon solvent carrier, typically a narrow-cut dearomatized kerosene with flash point exceeding 62°C. Application occurs via flood-coating or dip-treatment within 24 hours of sawing; delayed treatment allows fungal hyphae to penetrate beyond the 2–3 mm effective diffusion zone of the chemical, rendering subsequent biocide application ineffective. The treatment solution is supplemented with a water-repellent wax emulsion (3–5 wt%) that retards leaching during the 8–12 week air-drying period, during which treated lumber is stickered in open-sided sheds. Leaching data from EN 84 accelerated aging indicate that 18–24% of the initial biocide loading migrates into the first 2 mm of the wood surface after 14 days of water contact; this surface depletion rate is acceptable for lumber destined for interior framing applications (Use Class 1–2 per EN 335) but insufficient for ground-contact scenarios without co-biocide reinforcement using a triazole fungicide. Efficacy validation follows EN 152 (blue stain) and EN 113 (basidiomycete decay) protocols, with a minimum requirement of rating 1 on the 0–4 scale for sapstain coverage. Dip-tank operational controls include weekly replenishment of the biocide concentration based on active ingredient titration, with a tolerance band of ±0.15 wt% from the target. Solvent evaporation from the dip tank raises the biocide concentration over time; specific gravity monitoring by hydrometer at 20°C is implemented to trigger solvent makeup when density exceeds 0.820 g/cm³.
Cooling tower water systems operating with cycles of concentration between 4 and 8 accumulate dissolved solids that buffer pH above 8.5 and provide nutrient-rich surfaces for Legionella pneumophila amplification within amoebic hosts. The chlorinated benzisothiazole, when fed continuously at 3–7 mg/L active ingredient based on recirculating water volume, suppresses sessile bacterial counts on stainless steel coupons to below 10² CFU/cm², as enumerated by scraping and plate-count methods per ASTM D5465-16. Efficacy against Legionella specifically is assessed by qPCR targeting the mip gene; a 2-log reduction in genomic units is achievable within 48 hours of initial dosing, provided that the system is pre-cleaned of established biofilm deposits exceeding 100 µm thickness—below this threshold, biocide penetration is diffusion-limited rather than reaction-limited. The compound is fed from a day-tank where a 20% active solution in dipropylene glycol monomethyl ether is prepared; this solvent selection avoids the freezing-point depression issues of ethylene glycol-based carriers that would complicate discharge permits under US NPDES permits with whole effluent toxicity testing requirements. Oxidizing biocide programs (chlorine, bromine, chlorine dioxide) are paused 4 hours before and 2 hours after benzisothiazole addition, as free halogen residuals above 0.3 mg/L oxidize the thioether sulfur to sulfoxide and sulfone derivatives with significantly reduced antimicrobial activity. Blowdown water containing spent biocide passes through activated carbon filtration before discharge; breakthrough monitoring by UV absorbance at 280 nm triggers carbon bed replacement when effluent absorbance exceeds 0.05 AU. Published data for the specific combination of high-hardness water (> 400 mg/L as CaCO₃) and elevated cycles of concentration (> 10) with this biocide is limited; pilot-scale testing in a 500-L recirculating rig is advised before full-scale implementation in such conditions. Drilling fluid preservation in offshore oil and gas operations subjects biocides to extremes of temperature, salinity, and shear not encountered in industrial water treatment. In water-based muds formulated with xanthan gum and starch viscosifiers, 3-chloro-1,2-benzisothiazole is pre-solubilized in a mutual solvent (ethylene glycol monobutyl ether at 10–15% of the biocide package) and injected into the suction pit at 0.05–0.10 lb/bbl, corresponding to approximately 140–280 mg/L. The alkaline reserve of the mud, maintained by additions of caustic soda or lime to a Pm alkalinity of 1.0–2.5 mL of 0.1 N sulfuric acid, accelerates hydrolytic degradation at the upper end of this range; consequently, a split-dosing regimen—half the charge at the suction pit, half at the shale shaker trough—is employed to maintain a minimum effective concentration through the circulation cycle. Thermal aging tests in pressurized aging cells at 150°C for 16 hours, per API RP 13I, indicate a 35–40% reduction in active biocide, a loss factored into the initial dose calculation. Brine-based completion fluids saturated with sodium chloride or calcium chloride present a distinct challenge: the chlorinated benzisothiazole exhibits decreasing solubility as ionic strength increases, with measured precipitation at chloride concentrations exceeding 180,000 mg/L. In such systems, the biocide is limited to a maximum dose of 50 mg/L to avoid particle formation that would plug formation pores during well completion operations. The compound's compatibility with oxygen scavengers—specifically ammonium bisulfite catalyzed with cobalt—is a critical operational parameter. At ammonium bisulfite doses above 50 mg/L, the reducing environment dechlorinates the 3-position over 6–12 hours, producing the less active benzisothiazolinone; this incompatibility dictates that the two additives are injected at points separated by a minimum 30-minute transit time in the flowline. |
Competitive 3-Chloro-1,2-Benzisothiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Specification | Test Method |
|---|---|---|
| Assay (GC area‑%) | ≥ 98.0 % | GC‑FID, DB‑5 column, 30 m × 0.25 mm × 0.25 µm |
| Melting range | 38–40 °C | USP<741>, capillary method |
| Water content | ≤ 0.1 % | Karl Fischer coulometric titration (USP<921>) |
| Non‑volatile residue | ≤ 0.05 % | ASTM D1353‑13 |
| Residual solvents (GC‑HS) | Toluene ≤ 0.1 %, THF ≤ 0.1 % | ICH Q3C Guideline, Class 2 mixture |
| Heavy metals (as Pb) | ≤ 10 ppm | USP<231> Method II |
| Parameter | 3‑Chloro‑1,2‑benzisothiazole | 3‑Bromo‑1,2‑benzisothiazole | 3‑Iodo‑1,2‑benzisothiazole |
| Relative reactivity in Suzuki coupling (krel) | 1.0 | 4.2 | 11.5 |
| Approximate bulk cost (€ kg⁻¹) | 900‑‑1200 | 2300‑‑2800 | > 8000 |
| Hydrolytic stability (t1/2 in H2O/THF 1:1, 25 °C) | ~ 48 h | ~ 14 h | < 2 h |
| Commercial availability | Lab to multi‑kg scale | Gram to 10 kg | Gram scale, custom synthesis |